Cardiovascular Effects of Adderall in Healthy Young Adults


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-004743
    NCT ID: NCT02979327
    Sponsor Protocol Number: 16-004743

About this study

The purpose of this study is to determine blood pressure and heart rate changes (hemodynamic changes) in healthy adults after taking one dose of prescription medication Adderall 25 mg orally, and comparing the results to those of  a placebo pill. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:          

  • Adults 18 years of age and older
  • Healthy subjects without known cardiovascular disease, thyroid disease or documented mental health illness
  • Subjects who are not on any medications
  • Subjects with no prior history of regular amphetamine use, and non-prescription stimulants
  • Nonsmokers

Exclusion Criteria:         

  • Subjects with known cardiovascular disease, thyroid disease
  • Subjects with history of psychotic disorders/mental health illness, including but not limited to anxiety, depression, bipolar disorder; history of substance abuse or dependence
  • Subjects currently taking medications
  • Prior history of regular amphetamine use, or non-prescription stimulants
  • Smokers
  • Pregnant subjects
  • Known lactose intolerance (due to presence of lactose in the prepared medication)
  • Family history of sudden cardiac death

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Virend Somers, M.D., Ph.D.

Open for enrollment

Contact information:

Lisa Block


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer